Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 62 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1843. Clear
Clear
Q2
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q2
S-3 GROUP for VIATRIS (MYLAN, INC)
2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate · $60,000.00 income
Health Issues, Copyright/Patent/Trademark
View → Q2
BLUECROSS BLUESHIELD OF TENNESSEE for BLUECROSS BLUESHIELD OF TENNESSEE
2nd Quarter (Apr 1 - June 30) 2025 · Tennessee · House · Senate
Pharmacy, Medicare/Medicaid, Health Issues
View → Q2
FAEGRE DRINKER BIDDLE & REATH LLP for TEVA PHARMACEUTICALS USA, INC.
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $60,000.00 income
Health Issues, Copyright/Patent/Trademark
View → Q1
VIATRIS INC. for VIATRIS INC
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate
Health Issues, Copyright/Patent/Trademark, Trade (domestic/foreign), Financial Institutions/Investments/Securities
View → 1A
S-3 GROUP for VIATRIS (MYLAN, INC)
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $60,000.00 income
Health Issues
View → Q1
S-3 GROUP for VIATRIS (MYLAN, INC)
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $40,000.00 income
Health Issues
View → Q1
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy
View → RR
S-3 GROUP for VIATRIS (MYLAN, INC)
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania
Health Issues
View → Q1
FAEGRE DRINKER BIDDLE & REATH LLP for TEVA PHARMACEUTICALS USA, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate · $60,000.00 income
Health Issues, Copyright/Patent/Trademark
View → Q1
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark
View → Q1
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Previous Page 3 of 3

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem